Measles, mumps and rubella vaccine - MerckAlternative Names: M-M-RVAXPRO; MMR vaccine - Sanofi Pasteur
Latest Information Update: 13 Jan 2017
At a glance
- Originator sanofi pasteur MSD
- Developer Sanofi Pasteur
- Class Measles vaccines; Rubella vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Measles; Mumps; Rubella
Most Recent Events
- 02 Jan 2017 Sanofi Pasteur MSD ended their joint venture and will separately pursue their vaccine strategies in Europe